A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza VaccinesNeal Van Hoeven, Darrick Carter, Sharvari Waghmare Joshi et al.|Scientific Reports|2017Cited by 86
Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approachChristopher B. Fox, Steven G. Reed, Mark T. Orr et al.|Journal of Controlled Release|2016Cited by 65